Immune Thrombocytopenia Induced by Sintilimab in Lung Cancer:
A Case Report and Literature Review / 中国肺癌杂志
Chinese Journal of Lung Cancer
;
(12): 717-720, 2023.
Article
Dans Chinois
| WPRIM
| ID: wpr-1010079
ABSTRACT
Immune checkpoint inhibitors (ICIs) show unique advantages in the treatment of lung cancer, making the treatment of lung cancer enter the era of immunotherapy, but ICIs will also have adverse reactions, and the incidence of immune-induced hematological toxicity is not very high. Immunotherapy-induced thrombocytopenia is a rare adverse event.We report one case of thrombocytopenia induced by ICIs and review the literature on thrombocytopenia associated with ICIs and discuss the clinical features, possible mechanisms, and optimal treatment.
.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Thrombopénie
/
Purpura thrombopénique idiopathique
/
Anticorps monoclonaux humanisés
/
Tumeurs du poumon
Limites du sujet:
Humains
langue:
Chinois
Texte intégral:
Chinese Journal of Lung Cancer
Année:
2023
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS